Back

Natural history and prognostic significance of pulmonary hypertension in patients undergoing TAVR for severe aortic stenosis

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: TAVI: a new standard for aortic valve replacement? Aortic valve disease ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Brunilda Alushi

Conradia medical prevention, Munich (Germany)

4 More presentations in this session

Presentation thumbnail
State of the Art: TAVI indications and adoption: a dynamic field
Professor B. Prendergast (London, GB)
Video
Presentation thumbnail
Thirty-day and long-term outcomes after transcatheter aortic valve implantation from first-in-man to nowadays: 15 years experience of a pioneered center.
Professor E. Durand (Rouen, FR)
Abstract Slides Video
Presentation thumbnail
Worse outcome of patients with normal ejection fraction but low-gradient aortic valve stenosis after transcatheter aortic valve implantation (TAVI)
Doctor U. Fischer-Rasokat (Bad Nauheim, DE)
Abstract
Presentation thumbnail
TAVI complications: incidence, trends and management.
Professor A. Chieffo (Milan, IT)
Slides Video

Access the full session

Session thumbnail
TAVI: a new standard for aortic valve replacement?

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources